Merck & Co., Inc. (MRK) — closed signal from September 5, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on December 4, 2025.
Predicted vs. what happened
What happened
Reached its target in 69 days.
The thesis — published September 5, 2025
Merck looks like a steady, lower-drama choice for a short-term swing. Recent price signals suggest selling may have gone too far, and overall mood is positive, so it could drift back toward its usual range. An outside scoring model gave it 93% this week, backing the fundamentals. Demand for shelf-stable injectable medicines appears firm. Drug news can swing prices, but strong cash coming in and a wide pipeline support a 0-3 month move toward recent highs.
Primary drivers
- Short-term selling looks overdone, and buying interest is improving.
- Independent Peter Lynch-style score of 93% this week supports quality.
- Reliable cash generation and many drugs in market and development.
- Have a clear exit plan to handle surprise headlines in pharmaceuticals.
How it played out
MRK: target reached in 69 days
Lyra published MRK at 83.21 on 2025-09-05 for a short-term window ending 2025-12-04. The thesis expected 12% growth toward 91.50. It pointed to overdone selling, improving buying interest, a 93% Peter Lynch-style score, reliable cash generation, a broad drug base, and demand for shelf-stable injectable medicines.
Inside the window, MRK reached the target in 69 days. The peak was 104.94 on 2025-11-25, with a peak gain of 26.1%. It ended the window at 100.04. The published thesis played out, and the move went beyond the target.
What happened during the window
On 2025-10-30, Barron's reported that Merck posted third-quarter sales of 17.3 billion and non-GAAP earnings of 2.58 per share. The same article said Keytruda and Winrevair sales missed Wall Street estimates.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.